Your browser doesn't support javascript.
loading
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.
Bai, Jie; Wu, Bibo; Zhao, Shasha; Wang, Gang; Su, Shengfa; Lu, Bing; Hu, Yinxiang; Geng, Yichao; Guo, Zhengneng; Wan, Jun; OuYang, Weiwei; Hu, Cheng; Liu, Jie.
Afiliação
  • Bai J; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Wu B; Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Zhao S; Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Wang G; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Su S; Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Lu B; Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Hu Y; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Geng Y; Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Guo Z; Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Wan J; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • OuYang W; Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
  • Hu C; Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
  • Liu J; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
J Inflamm Res ; 15: 6357-6371, 2022.
Article em En | MEDLINE | ID: mdl-36424918
Purpose: To explore the effect of PD-1 inhibitors combined with irradiation on myocardial injury and the changes of HMGB1-associated inflammatory markers. Methods: Four groups of five mice were used, each groupformed by randomly dividing 20 mice (group A control; group B PD-1 inhibitors; group C Irradiation; group D PD-1 inhibitors+irradiation; n = 5 for each). The mice were treated with either PD-1 inhibitors or a 15 Gy dose of single heart irradiation, or both. Hematoxylin-eosin staining assessed the morphology and pathology of heart tissue; Masson staining assessed heart fibrosis; Tunel staining evaluated heart apoptosis; flow cytometry detected CD3+, CD4+, and CD8+ T lymphocytes in heart tissues; enzyme linked immunosorbent assay evaluated IL-1ß, IL-6, and TNF-ɑ of heart tissue; Western blot and quantitative real-time PCR (qPCR) detected the expression of protein and mRNA of HMGB1, TLR-4, and NF-κB p65 respectively. Results: The degree of heart injury, collagen volume fraction (CVF) and apoptotic index (AI) in groups B, C, and D were higher than group A, but the differences between the CVF and AI of group A and group B were not statistical significance (P>0.05). Similarly, the absolute counts and relative percentage of CD3+ and CD8+ T lymphocytes and the concentrations of IL-1ß, IL-6, and TNF-α in heart tissue with group D were significantly higher than the other groups (P<0.05). In addition, compared with group A, the expression of protein and mRNA of HMGB1 and NF-κB p65 in other groups were higher, and the differences between each group were statistically significant while TLR4 was not. In addition, interaction by PD-1 inhibitors and irradiation was found in inflammatory indicators, especially in the expression of the HMGB1 and CD8+ T lymphocytes. Conclusion: PD-1 inhibitors can increase the expression of HMGB1-associated inflammatory cytokines and aggravate radiation-induced myocardial injury.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article